The company’s innovations have not gone unnoticed. AI Medical Service was featured in 
SONIRE’s approach, which utilizes cavitation to enhance treatment accuracy, has been recognized by the U.S. FDA as a breakthrough device. The company is currently conducting a world-first randomized trial to further validate the efficacy of their technology. As CEO Satoh Tohru notes, the goal is to offer a more effective and safer cancer treatment to patients worldwide.
These Japanese startups are not only advancing medical technology but also providing hope for millions of cancer patients globally. As the world braces for a surge in cancer cases, innovations from companies like AI Medical Service and SONIRE Therapeutics could be pivotal in changing the landscape of cancer treatment.
Trump’s 2026 Mortgage Rate Prediction: What Real Estate Pros Should Really Expect
President Trump recently suggested mortgage rates will drop “a lot lower” by early 2026, sparking industry-wide curiosity — but current economic data tells a more measured story. With today’s 30‑year fixed hovering near 6.25%, experts say meaningful declines remain possible, though not guaranteed, and would depend on softer inflation, weaker economic signals, or a shift in bond market behavior. While political comments created headlines, analysts emphasize that only market conditions — not rhetoric — can drive rates down. Independent forecasts already point toward mid‑5% rates by 2026, offering a potentially healthier landscape for buyers, agents, and mortgage professionals preparing for the next cycle.
